NCT02574845View on ClinicalTrials.gov

DDI (Effect of Metformin and Furosemide on Rosuvastatin PK)

PHASE1CompletedINTERVENTIONAL
Enrollment

18

Participants

Timeline

Start Date

October 12, 2015

Primary Completion Date

December 9, 2015

Study Completion Date

December 14, 2015

Conditions
Healthy
Interventions
DRUG

Rosuvastatin

DRUG

Metformin HCl

DRUG

Furosemide

Trial Locations (1)

88397

Humanpharmakologisches Zentrum Biberach, Biberach

Sponsors
All Listed Sponsors
lead

Boehringer Ingelheim

INDUSTRY